Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

CLIFFORD ANTHONY REED

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1649281833
CMS profile
120010
Location
WEST READING, PA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2020 · Entire year

$57,305.28

161 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2020 · entire year · sorted by reported total

By paying entity

PY2020 · entire year · sorted by reported total

Paying entityAmountRecords
EMD Serono, Inc. $19,482.93 38
Biogen, Inc. $16,729.30 40
Celgene Corporation $8,950.28 20
GENZYME CORPORATION $6,754.63 15
Genentech USA, Inc. $4,285.42 7
Novartis Pharmaceuticals Corporation $496.41 18
Supernus Pharmaceuticals, Inc. $160.23 15
Genentech, Inc. $159.86 2
Teva Pharmaceuticals USA, Inc. $112.40 3
Allergan, Inc. $84.86 1
SANOFI-AVENTIS U.S. LLC $77.80 1
Akcea Therapeutics, Inc. $11.16 1

Page 3 of 4; records 101–150 of 161 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

CLIFFORD ANTHONY REED

NPI 1649281833 · CMS profile ID 120010

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neurology

WEST READING, PA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 4; records 101–150 of 161 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1649281833?year=2020&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
CLIFFORD ANTHONY REED, NPI 1649281833, CMS profile ID 120010. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 161 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1649281833?year=2020&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
APA 7
IndustryPayments. (2026). CLIFFORD ANTHONY REED, NPI 1649281833, CMS profile ID 120010. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 161 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1649281833?year=2020&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
Bluebook
CLIFFORD ANTHONY REED, NPI 1649281833, CMS profile ID 120010, IndustryPayments, General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 4; records 101–150 of 161 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019. https://industrypayments.org/provider/npi-1649281833?year=2020&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2020 · Physicians and non-physician practitioners · CMS publication 2026-06-30

161 matching records · $57,305.28 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 161 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 161.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Celgene Corporation $4.0002/22/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 727869587 CMS
Celgene Corporation $85.3402/22/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 727869591 CMS
Celgene Corporation $2,625.0002/22/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 727869595 CMS
Celgene Corporation $8.1002/22/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 727869601 CMS
Celgene Corporation $29.4602/22/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 727869603 CMS
Celgene Corporation $60.0002/22/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 727869607 CMS
Celgene Corporation $125.0002/22/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 727869609 CMS
Novartis Pharmaceuticals Corporation $6.7402/20/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 726097259 CMS
Biogen, Inc. $11.6302/19/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744539927 CMS
Supernus Pharmaceuticals, Inc. $8.3302/14/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 748358103 CMS
EMD Serono, Inc. $12.6302/12/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751274395 CMS
Genentech, Inc. $39.0902/10/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 742998765 CMS
GENZYME CORPORATION $273.7002/08/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744035588 CMS
GENZYME CORPORATION $214.2502/08/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744035597 CMS
GENZYME CORPORATION $2,532.0002/08/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744035601 CMS
GENZYME CORPORATION $39.2402/08/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744035608 CMS
GENZYME CORPORATION $100.6402/08/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744035615 CMS
GENZYME CORPORATION $4.0002/08/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744035621 CMS
GENZYME CORPORATION $8.5902/08/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744035629 CMS
GENZYME CORPORATION $85.3402/08/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744035635 CMS
GENZYME CORPORATION $31.1002/08/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744035641 CMS
GENZYME CORPORATION $60.0002/08/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744035649 CMS
GENZYME CORPORATION $51.8702/08/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744035653 CMS
GENZYME CORPORATION $121.9002/08/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744035659 CMS
Teva Pharmaceuticals USA, Inc. $82.3302/06/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 749525639 CMS
Genentech USA, Inc. $2,530.0002/05/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 857140491 CMS
Genentech USA, Inc. $89.7102/05/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 857140495 CMS
Biogen, Inc. $9.6902/01/2020 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744539901 CMS
EMD Serono, Inc. $56.6001/30/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751269925 CMS
EMD Serono, Inc. $3.5401/25/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751271991 CMS
EMD Serono, Inc. $31.7301/25/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751272243 CMS
EMD Serono, Inc. $12.6101/25/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751272479 CMS
EMD Serono, Inc. $15.7701/25/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751272721 CMS
EMD Serono, Inc. $52.5901/25/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751272973 CMS
EMD Serono, Inc. $12.6301/25/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751273319 CMS
EMD Serono, Inc. $23.0101/25/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751273451 CMS
EMD Serono, Inc. $542.8801/25/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751298491 CMS
EMD Serono, Inc. $1,175.8201/24/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751270989 CMS
EMD Serono, Inc. $2.8901/24/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751271235 CMS
EMD Serono, Inc. $7.7301/24/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751271487 CMS
EMD Serono, Inc. $82.1701/24/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751271739 CMS
EMD Serono, Inc. $2,580.0001/23/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751300353 CMS
EMD Serono, Inc. $2,580.0001/23/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751300419 CMS
Novartis Pharmaceuticals Corporation $9.8201/21/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 726097257 CMS
Novartis Pharmaceuticals Corporation $8.2901/17/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 726097253 CMS
Genentech USA, Inc. $12.3301/16/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 742998757 CMS
Biogen, Inc. $6.8401/15/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744539925 CMS
Biogen, Inc. $296.6001/11/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744539929 CMS
Biogen, Inc. $85.3401/11/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744539933 CMS
Biogen, Inc. $17.1701/11/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744539935 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $140,016.67 303
PY2020 $57,305.28 161
PY2021 $43,381.48 113
PY2022 $43,553.46 106
PY2023 $21,716.16 82
PY2024 $2,851.26 47
PY2025 $2,141.64 40

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $188,209.88 5
PY2024 Principal investigator $144,004.18 5
PY2023 Recipient $3,427.73 3
PY2023 Principal investigator $222,784.57 4
PY2022 Principal investigator $14,641.85 1

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

5 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Novartis Pharmaceuticals Corporation $118.05 10/28/2025 Non-covered Recipient Entity
READING HOSPITAL AMBULATORY PHARMAC
A Randomized, Double-blind, Double-dummy, Parallel-group Study, Comparing the Efficacy and Safety of Remibrutinib Versus Teriflunomide in Participants With Relapsing Multiple Sclerosis, Followed by Extended Treatment With Open-label Remibrutinib No dispute reported 06/30/2026 1190305103
Principal investigator 1 Novartis Pharmaceuticals Corporation $8,670.50 05/13/2025 Covered Recipient Teaching Hospital
Reading Hospital And Medical Center
A Randomized, Double-blind, Double-dummy, Parallel-group Study, Comparing the Efficacy and Safety of Remibrutinib Versus Teriflunomide in Participants With Relapsing Multiple Sclerosis, Followed by Extended Treatment With Open-label Remibrutinib No dispute reported 06/30/2026 1190296753
Principal investigator 1 EMD Serono, Inc. $22,220.00 03/05/2025 Covered Recipient Teaching Hospital
Reading Hospital And Medical Center
A Multicenter, Observational Study to Characterize the Clinical Course in a Real-World, US Cohort of Patients with Relapsing Multiple Sclerosis of Advanced Age (>50 years) Treated with Cladribine Tablets (AGING Study) No dispute reported 06/30/2026 1240117876
Principal investigator 1 EMD Serono, Inc. $4,700.00 03/05/2025 Covered Recipient Teaching Hospital
Reading Hospital And Medical Center
A Multicenter, Observational Study to Characterize the Clinical Course in a Real-World, US Cohort of Patients with Relapsing Multiple Sclerosis of Advanced Age (>50 years) Treated with Cladribine Tablets (AGING Study) No dispute reported 06/30/2026 1240117880
Principal investigator 1 Novartis Pharmaceuticals Corporation $152,501.33 01/21/2025 Non-covered Recipient Entity
READING HOSPITAL AMBULATORY PHARMAC
A Randomized, Double-blind, Double-dummy, Parallel-group Study, Comparing the Efficacy and Safety of Remibrutinib Versus Teriflunomide in Participants With Relapsing Multiple Sclerosis, Followed by Extended Treatment With Open-label Remibrutinib No dispute reported 06/30/2026 1190305105